| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00279611 |
| P698 | PubMed publication ID | 3311859 |
| P2093 | author name string | D Daneman | |
| R M Ehrlich | |||
| E B Sochett | |||
| C Clarson | |||
| P2860 | cites work | Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus | Q39479098 |
| Free insulin, bound insulin, C-peptide and the metabolic control in juvenile onset diabetics: comparison of C-peptide secretors and non-secretors during 24 hours conventional insulin therapy | Q39711513 | ||
| Residual Beta-cell Function and Its Metabolic Consequences | Q39718397 | ||
| C-Peptide Measurement: Methods and Clinical Utility | Q40177468 | ||
| Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood | Q40369831 | ||
| Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-peptide response to intravenous glucagon | Q40837864 | ||
| beta-cell function in children with diabetes | Q40866874 | ||
| Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement | Q40943941 | ||
| C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control | Q41233625 | ||
| Metabolic Control in Diabetic Patients: Effect of Insulin-secretory Reserve (Measured by Plasma C-Peptide Levels) and Circulating Insulin Antibodies | Q41624445 | ||
| C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide | Q42466801 | ||
| Residual beta-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve | Q42522257 | ||
| Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients | Q44888543 | ||
| Natural course of insulin resistance in type I diabetes. | Q51633221 | ||
| Metabolic control in 131 juvenile-onset diabetic patients as measured by HbA1c: relation to age, duration, C-peptide, insulin dose, and one or two insulin injections. | Q51650530 | ||
| C-peptide in children with juvenile diabetes. A preliminary report. | Q51669216 | ||
| Radioimmunological determination of human C-peptide in serum | Q51672193 | ||
| Effects of glucose on the ultrastructure and insulin biosynthesis of isolated mouse pancreatic islets maintained in tissue culture | Q54116261 | ||
| Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes | Q58169822 | ||
| Insulin secretory reserve in insulin dependent patients at time of diagnosis and the first 180 days of insulin treatment | Q58170102 | ||
| The pancreatic islets in diabetes | Q67262870 | ||
| Diabetic Ketoacidosis: Evidence for C-Peptide and Proinsulin Secretion following Recovery | Q69376149 | ||
| Sequential Changes in Beta-Cell Function in Insulin-Treated Diabetic Patients Assessed by C-Peptide Immunoreactivity | Q69383844 | ||
| Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin Treatment | Q70311233 | ||
| Evidence of delayed beta-cell destruction in type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies | Q70402093 | ||
| Beta-cell function recovery is not the only factor responsible for remission in type I diabetics: evaluation of C-peptide secretion in diabetic children after first metabolic recompensation and at partial remission phase | Q70403005 | ||
| An automated "high-pressure" liquid-chromatographic assay for hemoglobin A1c | Q70642022 | ||
| The early partial remission of juvenile diabetes mellitus. The roles of insulin and growth hormone | Q72355184 | ||
| P433 | issue | 7 | |
| P921 | main subject | type-1 diabetes | Q124407 |
| P304 | page(s) | 453-459 | |
| P577 | publication date | 1987-07-01 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children | |
| P478 | volume | 30 |
| Q50918709 | Age governs gender-dependent islet cell autoreactivity and predicts the clinical course in childhood IDDM. |
| Q59487906 | Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis |
| Q84940117 | Beta-cell autoantibodies and their function in Taiwanese children with type 1 diabetes mellitus |
| Q35561483 | CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes |
| Q51623763 | Changes in endogenous insulin secretion during childhood as expressed by plasma and urinary C-peptide. |
| Q51444739 | Clinical manifestations and beta cell function in Swedish diabetic children have remained unchanged during the last 25 years. |
| Q80824131 | Dynamic changes in CD4+ CD25+(high) T cell apoptosis after the diagnosis of type 1 diabetes |
| Q93515122 | Effect of nicotinamide treatment on the residual insulin secretion in type 1 (insulin-dependent) diabetic patients |
| Q33312930 | Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus |
| Q42261993 | Factors Associated with C-peptide Levels after Diagnosis in Children with Type 1 Diabetes Mellitus |
| Q34630900 | Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. |
| Q44606337 | Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis |
| Q44893510 | Guidelines for Intervention Trials in Subjects With Newly Diagnosed Type 1 Diabetes |
| Q64954344 | Increasing prevalence of diabetic ketoacidosis at diabetes diagnosis among children in Quebec: a population-based retrospective cohort study. |
| Q68622409 | Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year |
| Q55451980 | Integration of Routine Parameters of Glycemic Variability in a Simple Screening Method for Partial Remission in Children with Type 1 Diabetes. |
| Q68146906 | Islet-cell antibodies and endogenous insulin secretion in Sudanese diabetic children |
| Q34800286 | Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group |
| Q38666229 | Management of diabetes mellitus |
| Q36520464 | Managing diabetes mellitus in children and adolescents: some guidelines for family physicians |
| Q51620813 | Metabolic effect of islet B-cell function in insulin-treated diabetes. |
| Q37269446 | New definition for the partial remission period in children and adolescents with type 1 diabetes |
| Q37381466 | Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis |
| Q24600478 | Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay |
| Q90731433 | Persistent elevations in circulating INS DNA among subjects with longstanding type 1 diabetes |
| Q37437814 | Prediction, prevention, and early intervention in insulin-dependent diabetes. |
| Q29994508 | Predictors of glycemic control in the first year of diagnosis of childhood onset type 1 diabetes: A systematic review of quantitative evidence |
| Q37364982 | Preservation of beta-cell function in autoantibody-positive youth with diabetes |
| Q35859389 | Preserved C-peptide levels in overweight or obese compared with underweight children upon diagnosis of type 1 diabetes mellitus |
| Q37640355 | Prevention of type 1 diabetes |
| Q43447934 | Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus |
| Q72221869 | Serum insulin profiles in consecutive children 2 years after the diagnosis of IDDM |
| Q36181700 | Spontaneous complete remission of type 1 diabetes mellitus in an adult - review and case report |
| Q42451970 | The C-peptide response to a standard mixed meal in a group of Brazilian type 1 diabetic patients |
| Q44679778 | The severity of clinical presentation of type 1 diabetes in children does not significantly influence the pattern of residual beta-cell function and long-term metabolic control |
| Q79344309 | The variable but inevitable loss of beta cells in overt type 1 diabetes |
| Q69520358 | Type 1 (insulin-dependent) diabetes in Japanese children is not a uniform disease |
| Q28301396 | Type 1 diabetes |
Search more.